ArticleCureus2026
Persistent Asymptomatic Pancreatic Hyperenzymemia or Gullo's Syndrome: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elevated pancreatic enzymes usually point towards pancreatic disease. In the absence of supporting clinical and imaging findings, interpretation of such elevation is challenging. We report the case of a 53-year-old man who presented with incidentally detected asymptomatic elevation of serum amylase and lipase. He was then investigated extensively without yielding remarkable laboratory or imaging findings. He was closely followed up for two years to determine the benign course of the syndrome. He remained asymptomatic without any additional imaging findings. A diagnosis of benign pancreatic hyperenzymemia or Gullo's syndrome was made. Benign pancreatic hyperenzymemia is a syndrome characterized by persistently elevated pancreatic enzymes in the absence of any underlying pancreatic disease (amylase ranged 236-520 U/L and lipase 257-956 U/L over 28 months, and two endoscopic ultrasonography (EUS) examinations (24 months apart) showed stable non-diagnostic lobularity without honeycombing). It is a diagnosis of exclusion. Treatment is reassurance and avoidance of costly re-investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.